Home › Lung Diseases › Colorado › Aurora
Lung Diseases clinical trials in Aurora, CO
3 studies for Lung Diseases are looking for participants at sites in and around Aurora (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
RecruitingPhase 3
- UCHealth Anschutz Inpatient Pavilion - Anschutz Medical Campus, Aurora
- University of Colorado Anschutz Medical Campus, Aurora
- University of Colorado Clinical and Translational Research Center, Aurora
- and 1 more
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
- University of Colorado Cancer Center, Aurora
Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease
RecruitingObservational study
- University of Colorado - Anschutz Medical Campus, Aurora
About Lung Diseases
Lung diseases are disorders or infections that affect the lungs and cause breathing problems. Some can lead to respiratory failure. Find out more about prevention, living with lung diseases, and treatment.
More about Lung Diseases on MedlinePlus
Lung Diseases trials in other cities
- Houston, TX15 studies
- Boston, MA14 studies
- Durham, NC13 studies
- New York City, NY12 studies
- Pittsburgh, PA11 studies
- Los Angeles, CA10 studies
- Columbus, OH10 studies
- Dallas, TX10 studies
- Nashville, TN10 studies
- Washington, DC10 studies
- Miami, FL10 studies
- Ann Arbor, MI10 studies
Other studies in Aurora
- Cancer (all types)35 studies
- Colorectal Cancer32 studies
- Non-Small Cell Lung Cancer30 studies
- Breast Cancer27 studies
- Metastatic Cancer25 studies
- Ovarian Cancer25 studies
- Type 1 Diabetes23 studies
- Obesity21 studies
- Lung Cancer19 studies
- Prostate Cancer19 studies
- Heart Failure18 studies
- Melanoma18 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.